Leading UK law firm Freeths has advised Bioceres Group, a global frontrunner in life sciences, on its strategic business combination with Moolec Science, a company listed on NASDAQ.

This high-impact and technically complex transaction merges Bioceres’ cutting-edge expertise with Moolec’s proprietary capabilities in food ingredients, ag-biologicals, precision fermentation, biomaterials, and R&D services. The combination strengthens Moolec’s position as a differentiated life science platform, delivering sustainable innovations from molecule to ingredient.

Leading the Freeths team was M&A Partner and Head of Freeths International Emily Settle, alongside the wider Freeths team including Partners Lottie Hugo and Natalie Drought, Senior Associate Cormac Hayes, Associate Ben Treasure, Trainee Solicitor William Hardcastle-Foster and Trainee Solicitor Apprentice Pippa Johnson.

Commenting on the deal, Emily Settle (Head of Freeths International and Lead M&A Partner for the deal) said: “This combination of two of global flagship life sciences groups is another showcase of Freeths International’s strong advisory credentials for global transactions, in this case across the UK, Latin America and Cayman. This was a complex transaction and related reorganisation, delivered closely with the leadership of Bioceres General Counsel Gloria Montaron Estrada and Dante Dagostino. We were also delighted to work once again with our close partners Linklaters and Linklaters São Paulo, with Mathew Poulter and Caroline Aguiar acting for Moolec.”